Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Cyclosporin A 0.05% Eye Drops for Management of Symptomatic Acquired Punctal Stenosis. A Prospective, Controlled Clinical Study.

NCT05771012 is registered in ClinicalTrials.gov with Farwaniya Hospital as lead sponsor.

NCT NCT05771012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05771012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Cyclosporin A 0.05% Eye Drops for Management of Symptomatic Acquired Punctal Stenosis. A Prospective, Controlled Clinical Study.
Lead sponsor
Farwaniya Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2021
Completion date
December 1, 2022
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

management of punctal stenosis